Study Support Application - Covidence

Overview
Evidence-based consensus recommendations published by experts in the management of disease are a critical fiber of the healthcare fabric. Healthcare providers rely on guidelines and expert recommendations to inform treatment decisions and insurance providers rely on these to design formularies. Researchers compare new therapeutic or procedural interventions to standard-of-care practice guidelines in randomized controlled trials. However, many diseases still lack up-to-date recommendations or expert consensus recommendations, resulting in wide variability in practice patterns, and leaving many patients without access to treatment they need. Evidence-based guidelines and expert consensus best practice recommendations are lacking for many pediatric skin diseases.

To help PeDRA members work towards developing expert guidelines or consensus recommendations, PeDRA offers support in the way of Covidence, a leading software for managing and streamlining your systematic review.

Applicant Eligibility
Applicant must be an active PeDRA member and principal investigator working on an IRB-approved or IRB-exempt PeDRA Study. 

Important Dates
Applications will be accepted on a rolling basis and will be notified of the outcome of their application within three weeks.

Applications are noncompetitive and will be evaluated based upon eligibility and the availability of the program.